(November 23, 2022, 1:11 PM EST) -- SILVER SPRING, Md. — The Food and Drug Administration announced Nov. 22 that it is investigating risk of severe hypocalcemia in certain patients getting injections of Prolia brand denosumab, an osteoporosis drug for women....